East coast rail and intermodal carrier CSX Corp. (NYSE: CSX - $67.56) said its board approved increasing the quarterly dividend by 9% to $0.24 a share. The dividend will be paid on March 15 to shareholders of record on Feb. 28. The new $0.96 annual rate will yield 1.4%.
French integrated energy giant Total SA (NYSE: TOT - $54.77) reported adjusted net profit rose in the fourth quarter to $3.16 billion from $2.87 billion a year earlier, largely as a result of increased production volumes and reduced costs. On a per share basis, the company said it earned $1.17 compared to $1.10 last year and in… Continue reading Total Reports 4th Quarter Results: Increases Dividend
The investment of the ALPS Sector Dividend Dogs exchange traded fund (NYSE: SDOG - $42.62) seeks investment results that closely replicates, before fees and expenses, the performance of the S-Network-Sector Dividend Dogs Index. The underlying index generally consists of 50 stocks on each annual reconstitution date, which is the third Friday of December each year.… Continue reading ALPS Sector Dividend Dogs – Update
Industrial conglomerate 3M Co. (NYSE: MMM - $202.03) said its board boosted its quarterly dividend by 6% to $1.44 per share from $1.36. The annual payout based on the new dividend rate will be $5.76 per share, yielding about 2.8%. The quarterly dividend is payable March 12 to shareholders registered on Feb. 15. 3M has increased its dividend for 61 consecutive… Continue reading 3M Boosts Dividend
Health information services provider Cerner Corp. (NASDAQ: CERN - $57.99) reported fourth quarter revenue of $1.366 billion, an increase of 4% compared to the fourth quarter of 2017, but about 2% less than analysts were expecting. Adjusted net earnings for the period was $208.1 million, compared to $195.7 million a year ago. Adjusted earnings per share was in… Continue reading Cerner Reports in Line; Initiates Dividend
Forrest City, California biotech Gilead Sciences, Inc. (NASDAQ: GILD - $70.05) reported fourth-quarter earnings results that fell short of Wall Street estimates as sales of its flagship hepatitis C drugs continued to slide. Revenue decreased to $5.80 billion from $5.95 billion a year ago but beat the analyst consensus of $5.52 billion. Sales of Gilead's HIV drugs rose to $4.1 billion from $3.4… Continue reading Gilead Misses Profit Estimates; Hikes Dividend
Stocks continued to do well as we closed out the first month of the year. The Dow Industrials provided investors with a 327-point gain for the week or 1.3%. The S&P 500 and the Nasdaq Composite showed similar percentage gains, thanks in part to dovish comments from Federal Reserve Chair Jerome Powell. Earnings results from… Continue reading Week in Review